Sanofi, friends stage anti-cancer skating extravaganza

Share this article:

Sanofi-Aventis is partnering with four major cancer patient groups and Wachovia to produce a star-studded series of events aimed at raising awareness of women's cancers.

The two-year campaign debuts Oct. 14 with “Frosted Pink, presented by Sanofi-Aventis and Wachovia,” a TV special featuring celebrities like Sharon Osbourne and William Baldwin and musicians including Heart, Rascal Flatts, Kenneth “Babyface” Edmonds, Anastacia and Joss Stone along with figure skaters like Peggy Fleming, Oksana Baiul and Sasha Cohen.

The figure skating community has been hard hit by breast cancer and other women's cancers, a spokeswoman for the campaign said, and each of the show's stars has a personal connection to women's cancers.

The TV event, appearing on ESPN and ABC, is intended to drive viewers to the Web site, frostedpink.org. Organizers hope to see a community develop on the site, whose sponsors also include Merck Oncology and Bristol Myers-Squibb, along with a host of retailers, media properties and packaged goods brands.

Next year's “Pink with a twist” event will focus on gymnasts, including Shawn Johnson. The events were conceived by Edge Entertainment.

The campaign brings together an unusual constellation of patient advocacy groups, including The National Breast Cancer Coalition, The National Coalition for Cancer Survivorship, The Gynecologic Cancer Foundation and the Ovarian Cancer National Alliance.

Sanofi-Aventis products include Taxotere, indicated for breast cancer in both early and metastatic phases.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...